Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIBDOSE
NCT05534945Completed
- Start
- Dec 2022
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine, fentanyl and epinephrine in acute postoperative pain (12 arms). Primary endpoint: Successful analgesia at 1 day. Started Dec 2022; status: completed.
02
Drugs
bupivacainefentanylepinephrine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT05534945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534945.